Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
865 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Treatment Patterns in Metastatic Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: Xofigo (Radium 223 dichloride,BAY88-8223)
22 Recruiting A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Condition: Prostatic Neoplasms
Intervention: Other: Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
23 Recruiting Carboplatin in Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: Carboplatin
24 Recruiting Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection
Condition: Prostatic Neoplasms
Intervention: Drug: Hyperpolarized Pyruvate (13C) Injection
25 Recruiting Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Prednisone;   Drug: Enzalutamide
26 Recruiting Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Cabozantinib;   Drug: Docetaxel;   Drug: Prednisone
27 Recruiting Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: HypoIGRT
28 Recruiting Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: PROSTVAC V/F;   Drug: Ipilimumab
29 Not yet recruiting Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
Condition: Prostatic Neoplasms
Intervention: Drug: Somatostatin
30 Recruiting HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: HSV-tk +Valacyclovir in Combination with Brachytherapy
31 Not yet recruiting Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic Body Radiotherapy
32 Recruiting A Safety and Pharmacokinetics Study of Niraparib Plus Apalutamide in Men With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Niraparib;   Drug: Apalutamide
33 Not yet recruiting A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Intervention:
34 Recruiting A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)
Condition: Prostatic Neoplasms
Interventions: Biological: PF-06755992;   Biological: PF-06755990;   Device: TDS-IM Electroporation Device;   Biological: Tremelimumab;   Drug: Sunitinib;   Biological: PF-06801591
35 Recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention:
36 Recruiting Prostate Cancer Prospective Cohort
Condition: Prostate Cancer
Intervention:
37 Recruiting Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: Autologus elutriated monocyte placebo vaccine;   Biological: ME TARP vaccine
38 Recruiting A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants
Condition: Prostatic Neoplasms
Intervention:
39 Recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: JNJ-56021927
40 Recruiting A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
Condition: Prostatic Neoplasms
Intervention: Radiation: 11C-Choline

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.